Xi'an, China

Zhao Ma

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignees: Shaanxi Panlong Pharmaceutical Co., Ltd., Xixian New District Fenghou Original Pharmaceutical Technology Co., Ltd., Other. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhao Ma. Retrieved from https://idiyas.com/inventor/zhao-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 11.9

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Zhao Ma: Revolutionizing Technology in Xi'an

Introduction: Zhao Ma is a visionary inventor based in Xi'an, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Zhao Ma holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Zhao Ma has worked with leading tech companies and research institutions, playing a key role in developing cutting-edge solutions that have transformed industries.

Collaborations: Zhao Ma has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge sharing to drive progress in the tech sector.

Conclusion: Inventor Zhao Ma's relentless pursuit of innovation and his passion for creating a better future through technology make him a true pioneer in the field, inspiring the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…